Global X CleanTech vs GeneDx Holdings Corp — how do they compare? Global X CleanTech trades at $60.14, while GeneDx Holdings Corp trades at $82.71 (market cap $2.44B). The key difference: Global X CleanTech is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| CTEC | WGS | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $78.11 | $167.51 |
52-Week Low | $41.08 | $34.51 |
Market Cap | — | $2.44B |
Enterprise Value | — | $2.48B |
Signals from Pluang's Aura AI — not financial advice
CTEC trades at $60.26, up 3.9% with mixed technical signals showing bullish moving averages but overbought RSI levels. The stock faces immediate resistance at $60 with support at $58. Fundamental data remains limited pending updated SEC filings and earnings reports. A future dividend of $0.07 is scheduled for July 2026, indicating long-term capital return plans.
The outlook appears cautiously optimistic near-term given the bullish technical momentum, though overbought conditions warrant monitoring. Key risks include incomplete fundamental visibility and market volatility. Upside potential exists if the company demonstrates strong earnings growth when financials are updated.
GeneDx Holdings Corp (WGS) trades at $82.39, up 5.79% in the past 24 hours, with a bullish technical signal and strong analyst support. The company reported Q2 2026 revenue of $114.4 million, beating guidance, and returned to adjusted profitability earlier than expected. However, net income remains negative at -$106 million for 2026, and the stock faces class action lawsuits with an August 3, 2026 deadline.
Outlook is mixed: bullish technicals and analyst consensus suggest upside to the $90 price target, but fundamental weaknesses and legal risks pose significant challenges. Investment opportunity hinges on sustained revenue growth and margin improvement, while risks include profitability pressures and litigation outcomes.
Trailing returns across standard periods
CTEC invests in companies at the forefront of the clean technology industry. It focuses on disruptive innovations in renewable energy production, energy storage, smart grids, and energy efficiency, with top holdings like Enphase and First Solar.
Read more on CTEC →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →